NO20091467L - Farmasoytiske formuleringer som omfatter klopidogrel - Google Patents

Farmasoytiske formuleringer som omfatter klopidogrel

Info

Publication number
NO20091467L
NO20091467L NO20091467A NO20091467A NO20091467L NO 20091467 L NO20091467 L NO 20091467L NO 20091467 A NO20091467 A NO 20091467A NO 20091467 A NO20091467 A NO 20091467A NO 20091467 L NO20091467 L NO 20091467L
Authority
NO
Norway
Prior art keywords
clopidogrel
pharmaceutical formulations
melt granulate
pharmaceutically acceptable
melt
Prior art date
Application number
NO20091467A
Other languages
English (en)
Inventor
Helene Rey
Marc Fischer
Mathias Scheer
Original Assignee
Acino Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acino Pharma Ag filed Critical Acino Pharma Ag
Publication of NO20091467L publication Critical patent/NO20091467L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Smeltegranulat i form av en fast dispersjon av medikamentet i en farmasøytisk akseptabel bærer, hvori nevnte smeltegranulat omfatter en farmasøytisk aktiv forbindelse, fortrinnsvis klopidogrel, minst ett bæremateriale, og eventuelt farmasøytisk akseptable eksipienter og fremgangsmåte til fremstilling av nevnte smeltegranulat.
NO20091467A 2006-09-16 2009-04-15 Farmasoytiske formuleringer som omfatter klopidogrel NO20091467L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06019429A EP1900358A1 (en) 2006-09-16 2006-09-16 Pharmaceutical formulations comprising clopidogrel
PCT/EP2007/008070 WO2008031623A1 (en) 2006-09-16 2007-09-17 Pharmaceutical formulations comprising clopidogrel

Publications (1)

Publication Number Publication Date
NO20091467L true NO20091467L (no) 2009-04-15

Family

ID=37735123

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091467A NO20091467L (no) 2006-09-16 2009-04-15 Farmasoytiske formuleringer som omfatter klopidogrel

Country Status (16)

Country Link
US (1) US20090270448A1 (no)
EP (3) EP1900358A1 (no)
AT (1) ATE552826T1 (no)
AU (1) AU2007296854A1 (no)
CA (1) CA2663311A1 (no)
DE (1) DE202007019385U1 (no)
DK (1) DK2068838T3 (no)
ES (1) ES2384740T3 (no)
IL (1) IL197089A0 (no)
MX (1) MX2009002356A (no)
NO (1) NO20091467L (no)
NZ (1) NZ575153A (no)
PL (1) PL2068838T3 (no)
PT (1) PT2068838E (no)
RU (1) RU2009114206A (no)
WO (1) WO2008031623A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20150056T1 (hr) 2003-04-25 2015-04-24 Cadila Healthcare Limited Soli clopidogrela i postupak pripreme
EP1900358A1 (en) 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
CN102240269B (zh) * 2010-05-12 2013-04-10 天津泰普药品科技发展有限公司 结晶型硫酸氢氯吡格雷片剂的制备方法
EP2585161A1 (en) * 2010-06-23 2013-05-01 Stefan Kralev Medical device for self-administration of patients with acute coronary events
CN107501289B (zh) * 2017-09-07 2019-06-14 山东齐都药业有限公司 硫酸氢氯吡格雷有关物质d的制备方法
CN110339178B (zh) * 2019-06-28 2021-07-02 广州白云山天心制药股份有限公司 一种硫酸氢氯吡格雷固体制剂的制备方法
CN115737578A (zh) * 2022-11-23 2023-03-07 石家庄四药有限公司 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5308621A (en) * 1991-02-18 1994-05-03 Commonwealth Scientific And Industrial Research Organisation Ascorbic acid composition and transdermal administration method
JP3397385B2 (ja) * 1993-09-20 2003-04-14 第一製薬株式会社 崩壊遅延防止錠剤
HK1044476B (zh) * 1999-03-17 2010-09-17 第一制药株式会社 药物组合物
FR2792836B3 (fr) * 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
CA2363053C (en) 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
EP1900358A1 (en) * 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel

Also Published As

Publication number Publication date
ATE552826T1 (de) 2012-04-15
MX2009002356A (es) 2009-05-15
EP2068838B1 (en) 2012-04-11
ES2384740T3 (es) 2012-07-11
IL197089A0 (en) 2009-11-18
DK2068838T3 (da) 2012-07-09
PT2068838E (pt) 2012-06-27
EP2068838A1 (en) 2009-06-17
NZ575153A (en) 2011-01-28
CA2663311A1 (en) 2008-03-20
PL2068838T3 (pl) 2012-10-31
RU2009114206A (ru) 2010-10-27
AU2007296854A1 (en) 2008-03-20
WO2008031623A1 (en) 2008-03-20
DE202007019385U1 (de) 2012-03-29
EP2359810A2 (en) 2011-08-24
EP1900358A1 (en) 2008-03-19
US20090270448A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
IL197089A0 (en) Pharmaceutical formulations comprising clopidogrel
WO2008014175A3 (en) Granular pharmaceutical compositions
WO2007081948A3 (en) Bioadhesive drug formulations for oral transmucosal delivery
PT1827396T (pt) Medicamento oral de libertação modificada de pelo menos um princípio ativo sob forma multimicrocapsular
DE60330322D1 (de) Arzneimittel-mikroteilchen
JP2007504142A5 (ja) Ｈｉｖプロテアーゼ阻害薬固体分散物を含む固体薬物剤形
IL243709A0 (en) Devices, systems and methods for medicament delivery
WO2006055603A3 (en) Injectable nanoparticulate olanzapine formulations
CR20120661A (es) Dosificación en forma sólida para farmacéuticos
WO2009027644A3 (en) Compositions for the treatment of neoplastic diseases
PY0401585A (es) Formulaciones farmaceuticas liquidas de palonosetron
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
LTPA2019508I1 (lt) Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
ATE536861T1 (de) Bioerodierbare arzneimittelabgabesysteme mit verzögerter freisetzung
WO2008101173A3 (en) Biodegradable compositions and materials
HRP20050371A2 (en) Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
ZA200806138B (en) Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
SI1868581T1 (sl) Farmacevtski sestavki z izboljšanim profilom topnosti za slabo topna zdravila
PL1655026T3 (pl) Zawierające diacereinę i meloksikam stałe preparaty farmaceutyczne
DK1795186T3 (da) Flupirtinomfattende lægemiddelformulering med en kontrolleret frisætning af det aktive middel
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
DE602005027231D1 (de) Cylglycerolen und therapeutischen verwendungen derselben

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application